FOXO3 and breast carcinoma: Previous studies reported the overexpression of FOXO3 inhibited tumor growth in vitro and also reduced tumor size in vivo in breast cancer (40, 41) and thus, the lack of overexpression in our data (18%; 24/127) may point out the possible reason behind tumour progression.